Sexual Chemistry: A history of the contraceptive pill

Sexual Chemistry: A History of the Contraceptive Pill

Volumn , Issue , 2010, Pages 1-372

  Marks, Lara V ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902693906     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (650)

1. Mary Calderone, Schlesinger Library, Cambridge, Mass.
2. Clarence James Gamble, Francis Countway Library, Boston.
3. Alan Guttmacher, Francis Countway Library, Boston.
4. J. H., Hetherington, Archives and Manuscripts, Wellcome Library for the History and Understanding of Medicine, London.
5. Alan S. Parkes, Archives and Manuscripts, Wellcome Library for the History and Understanding of Medicine, London.
6. Gregory Pincus, Library of Congress, Washington DC.
7. John Rock, Francis Countway Library, Boston.
8. John Rockefeller III, Rockefeller Archive, Tarrytown, N.Y.
9. Margaret Sanger, Library of Congress, Washington DC.
10. Margaret Sanger, Sophia Smith Collection, Smith College, Northampton, Mass.
11. Alan Stone, Francis Countway Library, Boston.
12. Abortion Law Reform Association, Archives and Manuscripts, Wellcome Library for the History and Understanding of Medicine, London.
13. Birth Control Campaign, Archives and Manuscripts, Wellcome Library for the History and Understanding of Medicine, London.
14. Council for the Investigation of Fertility Control, Family Planning Association papers, Archives and Manuscripts, Wellcome Library for the History and Understanding of Medicine, London.
15. Food and Drug Administration papers, Washington DC.
16. Ford Foundation, Ford Foundation Archive, New York.
17. Medical Letter, Rockefeller Archive Center, Tarrytown, N.Y.
18. Medical Research Council, Public Records Office, Kew, Surrey.
19. Ministry of Health, Public Records Office, Kew, Surrey.
20. Planned Parenthood Federation of America papers, Sophia Smith Collection, Smith College, Northampton, Mass.
21. Planned Parenthood League of Massachusetts papers, Sophia Smith Collection, Smith College, Northampton, Mass.
22. Population Council, Rockefeller Archive, Tarrytown, N.Y.
23. Population Council, Ford Foundation Archive, New York.
24. Royal College of Obstetricians and Gynaecologists, London.
25. G. D. Searle, company headquarters in High Wycombe, UK.
26. Smithsonian Collection, National Museum of American History, Washington DC.
27. Worcester Foundation for Experimental Biology, Worcester Foundation papers, Shrewsbury, Mass.
28. Ridgeley C. Bennett, Washington DC.
29. Philip Corfman, Washington DC.
30. William Inman, Southampton.
31. Stephen Lock, London.
32. Klim McPherson, London.
33. Barbara Seaman, New York.
34. Susan Szasz, New York.
35. Geoffrey Venning, High Wycombe.
36. Martin Vessey, Oxford.
37. Victor Wynn, London.
38. Ridgeley C. Bennett, 30 Apr. 1996, Washington DC, notes.
39. Valerie Beral, 17 and 26 Dec. 1998, London, notes and tape.
40. Eliahu Caspi, 23 Mar. 1995, Worcester, Mass., notes.
41. Philip Corfman, May 1996, Washington DC., notes.
42. Emy Deva, 7 Nov. 1996, High Wycombe, transcript.
43. Carl Djerassi, 23 May 1994, London, notes and tape.
44. Celso Ramon Garcia, 16 Apr. 1995, Philadelphia, transcript.
45. Alejandro Hernandez, 8 Apr. 1997, Mexico City, tape (Spanish and English) notes, translator Felipe Lopez.
46. Roy Hertz, 21 Apr. 1995, Washington DC, notes.
47. Dot Hunt, 7 Apr. 1995, Worcester, Mass., transcript.
48. Jean Infield, 29 Jan. 1996, London, transcript.
49. William Inman, 13 Oct. 1994, Southampton, transcript.
50. Clifford Kay, 3 Dec. 1996, Manchester, transcript.
51. Francis Kelsey, 20 Feb. 1997, Washington DC, notes.
52. Judith McCann, 6 Apr. 1995, Worcester, Mass., notes.
53. John McCracken, 7 Apr. 1995, Worcester, Mass., notes.
54. Anne Merrill and Mary Ellen Fitts Johnson, 8 Apr. 1995, Worcester, Mass., transcript.
55. Luis Miramontes, 10 Apr. 1997, Mexico City, notes.
56. Joan Nabarro, 9 Dec. 1996, London, notes.
57. Denise Pullen, 16 Dec. 1996, Eastbourne, transcript.
58. Eli and Louisa Romanoff, 7 Apr. 1995, Worcester, Mass., tape, notes.
59. Adaline Satterthwaite, 27 Apr. 1995, Philadelphia, transcript.
60. Barbara Seaman, 12 May 1996, New York, notes.
61. Segal Sheldon, 30 Apr. 1996, Washington DC, notes.
62. Roger Short, 13 Nov. 1995, Oxford, notes.
63. Bruce Stradel, 30 Apr. 1996, Washington DC, transcript.
64. Ellen Tyler May, 13 May 1996, Minnesota, notes from telephone interview.
65. Geoffrey Venning, 16 Oct. 1996 and 7 Nov. 1996, London, notes.
66. Aviva Wiseman, 3 Mar. 1997, Slough, notes.
67. Victor Wynn, 6 Apr. 1994, London, transcript.
68. Mrs M.B., 15 Mar. 1997, transcript.
69. Mrs A.C., Autumn 1997, transcript, includes letter from Mrs A.C. to Lara V. Marks, n.d.
70. Mrs B.F., Autumn 1997, transcript.
71. Mrs J.F., 25 Mar. 1997, transcript.
72. Mrs M.F., Summer 1997, transcript.
73. Mrs C.H., Winter 1997, transcript.
74. Mrs D.R., Autumn 1997, transcript.
75. Mrs J.S., 25 Mar. 1997, transcript.
76. Mrs J.A.S., Autumn 1997, transcript.
77. Mrs S.S., Winter 1997, transcript.
78. Mrs R.T., Winter 1997, transcript.
79. Mrs R.W., Winter 1997, transcript.
80. Mrs P.C., 13 Nov. 1997, transcript.
81. Luis Miramontes, Mar. 1995, tape (Spanish) transcript, translated by Pilar Sanchez.
82. Mary Calderone, interviewed by James Reed, 7 Aug. 1974, transcript.
83. Elizabeth Arnold Cohen, interviewed by James Reed, Nov. 1974, transcript.
84. Mrs Alan Guttmacher, interviewed by James Reed, 15 Nov. 1974, transcript. Frances Ferguson Hand, interviewed by James Reed, June 1974, transcript.
85. Emily Mudd, interviewed by James Reed, n.d., transcript.
86. Stuart Mudd, interviewed by James Reed, 21 May 1974, transcript.
87. Edris Rice-Wray, interviewed by James Reed, 14 Mar. 1974, transcript.
88. Grant Sanger, interviewed by Ellen Chesler, Aug. 1976, transcript.
89. Adaline Satterthwaite, interviewed by James Reed, 19 June 1974, transcript.
90. Sarah and Christopher Tietze, interviewed by James Reed, 19 Dec. 1975, transcript.
91. Heather Bailey, tape C612/05/C612/06, transcript.
92. Maureen Delenian, tape, C612/02/C612/03, transcript.
93. Helen Gurley Brown, tape C612, transcript.
94. Denise Pullen, C612/07/08, transcript.
95. Betty Vincent, excerpts from the TV programme.
96. Jan Williams, tape C612/04, transcript.
97. Edris Rice-Wray, n.d. and no interviewer's name, transcript. Copy with Lynn Carson, daughter of Edris Rice-Wray, Mexico.
98. Contributers to Committee on Safety of Drugs (renamed Committee on Safety of
99. Medicines), Witness Seminar, 12 Mar. 1996, Wellcome Institute, transcript.
100. Contributers to The Pill, Witness Seminar, June 1995, Wellcome Institute, transcript.
101. Birmingham Post
102. British Medical Journal
103. Business Newsweek
104. Daily Express
105. Daily Mail
106. Daily Telegraph
107. Evening Chronicle
108. Evening News and Star (Cumberland)
109. Evening Standard
110. Financial Times
111. Guardian
112. Hospital Doctor
113. Independent on Sunday
114. Investors Chronicle
115. IPPF Medical Bulletin
116. Lancet
117. Manchester Guardian
118. Mid-Sussex Times
119. MIMS (Monthly Index of Medical Specialities)
120. Nature
121. Pharmaceutical Journal
122. Solihull, Warwick News
123. Spare Rib
124. Spectrum (newspaper of Family Planning and Human Conservation, published for Ortho Pharmaceutical Ltd).
125. Sunday Telegraph
126. Sunday Times
127. The Times
128. Windsor, Slough and Eton Express
129. Harpers
130. Journal of the American Medical Association
131. Medical News
132. New York Times
133. Newsweek
134. PDR (Physicians Desk Reference)
135. Sunday Dispatch
136. Washington Post
137. Worcester Sunday Telegram
138. Worcester Sunday Times
139. Japan Economic Newswire
140. Department of Health, 'NHS contraceptive services, England, 1998-99', Bulletin (Nov. 1999).
141. Government Act 1948, n and 12 Geo. 6, c. 26 (1947-48).
142. NHS Act 9 and 10 Geo. 6, c. 81 (1945-46), sec. 22.
143. Parliamentary Debates: House of Commons, vol. 685, 2 Dec. 1963; vol. 711, 26 Apr. 1965; vol 721, 29 Nov. 1965; vol. 729, 17 June 1966; vol. 744, 4 Apr. 1967; vol. 763, 30 Apr. 1968; vol. 783, 12 May 1969; vol. 793, 15 Dec. 1969. House of Lords, 5 June 1967.
144. The Population Problem: Correspondence between the Prime Minister the Rt. Hon. Harold Wilson MP and the Rt. Hon. Sir David Renton MP (Huntington, 1967).
145. Composite Report of the President's Committee to Study the United States Military Assistance Program, Vol. 1 (Government Printing Office, Washington DC, 17 Aug. 1959).
146. FDA Advisory Committee on Obstetrics and Gynecology, Report on Oral Contraceptives, (1 Aug. 1966).
147. FDA Advisory Committee on Obstetrics and Gynecology, Second Report on Oral Contraceptives, (1 Aug. 1969).
148. FDA Advisory Committee on Obstetrics and Gynecology, Minutes, 17 May 1968, 1 Apr. 1970,12 Oct. 1973, 6 Jan. 1977,11 Feb. 1982.
149. FDA Fertility and Maternal Health Drugs Advisory Committee Meetings, Minutes, 15 Jan. 1988, 28 Oct. 1993.
150. Population and the American Future: The Report of the Commission on Population Growth and the American Future (New York, 1972).
151. US Congress, House of Representatives, Hearings of the Subcommittee on Government Operations, Drug Safety, 1964, part 1
152. US Congress, House of Representatives, Intergovernmental Relations Subcommittee of the Committee on Government Operations, FDA Regulation of Oral Contraceptives, 15 July 1970.
153. US Congress, House of Representatives, Select Committee on Population, Report: Fertility and Contraception in the United States, Dec. 1978.
154. US Congress, Senate, Competitive Problems in the Drug Industry: Hearings before the Subcommittee on Monopoly of the Select Committee on Small Business, US Senate gist Congress, Second Session, on Present Status of Competition in the Pharmaceutical Industry, parts 15-17, Jan. -Mar. 1970 (Nelson hearings).
155. US Congress, Senate, Hearings before the Subcommittee on Foreign Expenditures of the Committee on Government Operations, 89th Congress, 2nd Session, June 1966.
156. US Congress, Senate, Hearings before the Subcommittee on Small Business, 90th Congress, 2nd Session, 1968, part 8.
157. US Congress, Senate, Interagency Coordination in Drug Research and Regulation, Hearings before the Subcommittee on Reorganization and International Organizations of the Committee on Government Operations, 1962-64, parts 1-5;
158. US Congress, Senate Subcommittee on Patents, Trademarks, and Copyrights of the Committee on the Judiciary, Wonder Drugs, Hearings on S. Res. 167, 84th Congress, 2nd Session, 1956.
159. US Congress, Senate, World Population and Food Crisis: Hearings before the Consultative Subcommittee on Economic and Social Affairs of the Committee on Foreign Relations, 29 June 1965.
160. Bennett, R. C., 'Impact of FDA regulation of oral contraceptives on public health: reduction of thromboembolism, myocardial infarction, and stroke', Remarks to the Society of Alumni, Johns Hopkins University School of Hygiene and Public Health Annual Meeting and Recognition Banquet, 14 Nov. 1988, Bennett's personal papers.
161. Bennett, R. C., 'Remarks to the Fertility and Maternal Health Drugs Advisory Committee', 15 Jan. 1988, Bennett's personal papers.
162. Bennett, R. C., 'The safety and utility of oral contraceptives containing 50 micrograms of estrogen', prepared for FDA Fertility and Maternal Health Drugs Advisory Committee meetings, 28 Oct. 1993.
163. Bennett, R. C., 'It's effective, but is it safe?: the pill', n.d., Bennett's personal papers.
164. Calderone, M. S., 'Family planning and sexuality: retrospect 1953-74', Worcester Foundation archives.
165. Guttmacher, A., 'The pill around the world', prepared for IPPF Medical Bulletin, Sept. 1966, AG-FCL, Box 18.
166. Harris, H., 'Clinical trials of Enovid in Kentucky, 1958-1969', presented to American Association for the History of Medicine, Apr. 1998.
167. Hertz, R. and Bailar, J. C., 'An appraisal of some unresolved problems involved in the use of estrogen-progestogen combinations for contraception', National Institutes of Health staff paper, Apr. 1964.
168. Inman, W., 'Memoirs', Inman's personal papers.
169. Jitsukawa, M. and Djerassi, C., 'Birth control in Japan: realities and prognosis'. I am grateful to Carl Djerassi for giving me a copy of this paper in manuscript form.
170. Sartwell, P., Masi, A. S., Arthes, F. G., Greene, G. R. and Smith, H. E. 'Thromboembolism and oral contraceptives: an epidemiological case-control study', in FDA Advisory Committee on Obstetrics and Gynecology, Minutes, 1 Aug. 1969.
171. Venning, G., 'Family planning and population policies in developed and less developed countries', for Clinics in Endocrinology and Metabolism, 2/3 (1973), G. D. Searle's papers, High Wycombe, UK.
172. Wiseman, A., 'The pill', n.d., c. 1966, Wiseman's personal papers.
173. Berg, S. M., 'Gregory Goodwin Pincus: from reproductive biology to the birth control pill. Underlying motivations and professional goals', B.A. thesis, Harvard University, 1989.
174. Courey, R. M., 'Participants in the development, marketing and safety evaluation of the oral contraceptive, 1950-1965: mythic dimension of a scientific solution', Ph.D. thesis, University of California, Berkeley, 1994.
175. Fisher, K., 'An oral history of birth control practice c. 1925-50: a study of Oxford and South Wales', D.Phil, thesis, Oxford, 1997.
176. Kelt, I., 'The medical profession and the pill', B.Sc. dissertation, Wellcome Institute, June 1998.
177. Vayena, E., 'Cancer detectors: an international history of the pap test and cervical cancer screening, 1928-1970', Ph.D thesis, University of Minnesota, Nov. 1999.
178. Vessey, M. P., 'Some epidemiological investigations into the safety of oral contraceptives', M.D. thesis, London University, 1970.
179. Abraham, J., Science, Politics, and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation (New York, 1995).
180. Ad Hoc Advisory Committee, 'FDA report on Enovid', JAMA, 185 (1963), 776.
181. 'Advantages of orals outweigh disadvantages', Population Reports, Series A, no. 2 (Mar. 1975).
182. Allitt, P., Catholic Intellectuals and Conservative Politics in America 1950-1985 (New York, 1993).
183. 'Another look at the pill and breast cancer', Lancet, 2 (2 Nov. 1985), 985-7.
184. Applezweig, N., 'The big steroid treasure hunt', Chemical Week, 84 (21 Jan. 1959), 37-51.
185. Applezweig, N., Steroid Drugs (New York, 1962).
186. Asbell, B., The Pill: A Biography of the Drug that Changed the World (New York, 1995).
187. Astwood, E. B., 'Progesterone inhibition of ovulation in the rat', American Journal of Physiology, 127 (1939), 127.
188. Bachrach, C. A., 'Contraceptive practice among young American women, 1973-1982', Family Planning Perspectives, 16/6 (1984), 253-9.
189. 'Backbench fury at proposal to charge women for the pill', Daily Telegraph, 1 Jan. 1998.
190. Bailey, B., 'Prescribing the pill: politics, culture, and the sexual revolution in America's heartland', Journal of Social History (Summer 1997), 827-56.
191. Baker, C. Looper and Kline, C. Baker, eds, The Conversation Begins: Mothers and Daughters Talk about Living Feminism (New York, 1996).
192. Bankole, A., Darroch J. E. and Singh, S., 'Determinants of trends in condom use in the United States, 1988-95', Family Planning Perspectives, 31/6 (Nov./Dec. 1999), 264-71.
193. Barrett, J., 'Product liability and the pill', Cleveland State Law Review, 19 (1970), 468-78, repr. in J. Katz, Experimentation with Human Beings: The Authority of the Investigator, Subject, Professionals and State in the Human Investigation Process (New York, 1972), 789-91.
194. Baum, J. F. et al., 'Possible association between benign hepatomas and oral contraceptives', Lancet, 2 (1973), 926-8.
195. Benn, M. and Richardson, R., 'Uneasy freedom: Women's experiences of contraception', Women's Studies International Forum, 7/4 (1984), 219-25.
196. Beral, V., 'Parity and susceptibility to cancer', in Fetal Antigens and Cancer, Ciba Foundation Symposium 96 (London, 1983), 182-203.
197. Beral, V., 'Childbearing, oral contraceptives and breast cancer', Lancet, 341 (1993), 110-12.
198. Beral, V., Fraser P., and Chilvers, C., 'Does pregnancy protect against ovarian cancer?', Lancet (20 May 1978), 1083-6.
199. Beral V. et al., 'Mortality associated with oral contraceptive use: 25-year follow-up of cohort of 46,000 women from Royal College of General Practitioners' oral contraception study', BMJ, 318 (9 Jan. 1999), 96-100.
200. Bertina, R. M. et al., 'Mutation in blood coagulation factor V associated with resistance to activated protein C', Nature 369/6475 (5 May 1994), 64-7.
201. Bhrolchain, M. N., 'The contraceptive confidence idea: an empirical investigation', Population Studies, 42 (1988), 205-25.
202. Bielschowsky F. and Horning, E. S., 'Aspects of endocrine carcinogenesis', British Medical Bulletin, 14/2 (1958), 106-15.
203. Biezanek, A., All Things New (New York, 1965).
204. Birch, A. J., 'Steroid hormones and the Luftwaffe. A venture into fundamental strategic research and some of its consequences: The Birch reduction becomes a birth reduction', Steroids, 57 (Aug. 1992), 363-77.
205. 'Birth control pills boom', Business Week, 23 Feb. 1963, 62-3.
206. 'Birth control: The pill and the church', Newsweek, 6 July 1964, 51-4.
207. Bland, L., Banishing the Beast: English Feminism and Sexual Morality 1885-1914 (London, 1995).
208. Blom, I., 'Voluntary motherhood 1900-1930: Theories and politics of a Norwegian feminist in an international perspective', in G. Bock and P. Thane, eds, Maternity and Gender Policies (London, 1991).
209. Bock, G., 'Antinatalism, maternity and paternity in National Socialist racism', in G. Bock and P. Thane, eds, Maternity and Gender Policies (London, 1991), 233-55.
210. Bock, G. and Thane, P., eds, Maternity and Gender Policies: Women and the Rise of European Welfare States, 1880s-1950s (London, 1991).
211. Bone, M., Family Planning Services in England and Wales (London, 1973).
212. 'The book that brought consumer advocacy to the medical system', Health Facts: Center for Medical Consumers, 20/196 (Sept. 1995), 3-4.
213. Borell, M., 'Brown-Sequard's organotherapy and its appearance in America at the end of the nineteenth century', Bulletin of the History of Medicine, 50/3 (Fall 1976), 309-20.
214. Borell, M., 'Organotherapy, British physiology, and the discovery of internal secretions', Journal of the History of Biology, 9/2 (Fall 1976), 235-68.
215. Boston Collaborative Drug Surveillance Programme, 'Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours', Lancet (23 June 1973), 1399-404.
216. Boston Women's Health Collective, Our Bodies, Ourselves (Boston, 1984).
217. Boyle, T. C., Riven Rock (Viking, 1998).
218. 'Breast cancer and the pill - a muted reassurance', BMJ, 282/6282 (27 June 1981), 2075-6.
219. Brinton L. A. et al., 'Risk factors for benign breast disease', American Journal of Epidemiology, 113/3 (Mar. 1981), 203-14.
220. Brinton L. A. et al., 'Oral contraceptives and breast cancer', International Journal of Epidemiology, 11/4 (1982), 316-22.
221. Brookes, B., Abortion in England, 1900-1967 (London, 1988).
222. Buck, P. S. 'The pill and the teenage girl', Reader's Digest (Apr. 1968), III.
223. Buehring, G. C., 'Oral contraceptives and breast cancer: What has 20 years of research shown?', Biomedicine and Pharmacotherapy, 42 (1988), 525-30.
224. Bullough, V. N., Science in the Bedroom: A History of Sex Research (New York, 1994).
225. Burt Gerstman, B. et al., 'Trends in the content and use of oral contraceptives in the United States, 1964-88', American Public Health Journal, 81/1 (Jan. 1991), 89-96.
226. Caldwell, J. and Caldwell, P., Limiting Population Growth and the Ford Foundation Contribution (London, 1986).
227. Cantor, D., 'Cortisone and the politics of empire: Imperialism and British medicine, 1918-1955', Bulletin of the History of Medicine, 67/3 (1993), 463-93.
228. Cartwright, A., Parents and Family Planning Services (London, 1970).
229. Cartwright, A., How Many Children? (London, 1976).
230. Cartwright, A., 'Family size, contraceptive practice and fertility intentions in England and Wales, 1967-1975, Family Planning Perspectives, 11/2 (1979), 128-37.
231. Cartwright, A., 'Trends in family intentions and the use of contraception among recent mothers, 1967-84', Population Trends, 49 (1987), 31-4, 33.
232. CASH, 'Long-term oral contraceptive use and risk of breast cancer', JAMA, 249 (1983), 1591-5.
233. CASH, 'Oral contraceptive use and the risk of ovarian cancer', JAMA, 249 (1983), 1596-9.
234. CASH, 'Oral contraceptive use and the risk of breast cancer', New England Journal of Medicine, 315/7 (1986), 405-11.
235. CASH, 'Breast cancer and hormonal contraceptives: Further results', Contraception, 53/3S (1996), is-io6s.
236. CASH, 'Breast cancer and hormonal contraceptives', Lancet, 347 (22 June 1996), 1713-27.
237. Cassagrande, J. T. et al., 'Incessant ovulation and ovarian cancer', Lancet (28 July 1979), 170-3.
238. Chang, M. C. and Pincus, G., 'Does phosphorylated hesperidin affect fertility?', Science, 117 (13 Mar. 1953), 274-6.
239. ChenSee, S., Women in Science (Canadian Science Writers' Association, 1999).
240. Chesler, E., Woman of Valor: Margaret Sanger and the Birth Control Movement in America (New York, 1992).
241. Chivers C. E. D. and Deacon, J. M., 'Oral contraceptives and breast cancer', British Journal of Cancer 61/1 (1990), 1-4.
242. Clarke, A., 'Controversy and the development of reproductive sciences', Social Problems, 37 (1990), 18-37.
243. Colton, F. B., 'Steroids and the Pill: Early steroid research at Searle', Steroids, 57 (Dec. 1992), 624-30.
244. Committee on Safety of Medicines, Combined Oral Contraceptives and Thromboembolism (London, 1995).
245. Cook, R., Human Fertility: The Modern Dilemma (New York, 1951).
246. Cookson, C., 'The nature of things: new conclusions from old studies', Financial Times, 26-27 Nov. 1994, 3.
247. Coughlan, R., 'Control challenge: Science is near success in a search for way to curb runaway population', Life, 21 Nov. 1959, 159-76.
248. Cova, A., 'French feminism and maternity: theories and policies 1890-1918', in G. Bock and P. Thane, eds, Maternity and Gender Policies (London, 1991).
249. Crapo, L., Hormones: The Messengers of Life (Stanford, 1985).
250. Critchlow, D., Intended Consequences: Birth Control, Abortion, and the Federal Government in Modern America (Oxford, 1999).
251. Crossman, R., The Diaries of a Cabinet Minister, vol. 3: Secretary of State for Social Services, 1968-70 (London, 1977).
252. Curtis Wood, H., 'Unplanned children: Whose burden? Whose care?', Medical Opinion and Review (Mar. 1966), 28-35.
253. Cutler, B. S., 'Endometrial carcinoma after stilboestrol therapy in gonadal dysgenesis', New England Journal of Medicine, 287 (1972), 628.
254. Dahlback, B., 'Factor V and protein S as cofactors to activated protein C', Haemotologica, 82/1 (Jan.-Feb. 1997), 91-5.
255. Dale, H. E., 'The chemistry of sex hormones', Pharmaceutical Journal (29 Apr. 1939), 432-41.
256. Darroch, J. E., 'The pill and men's involvement in contraception', Family Planning Perspectives, 32/2 (Mar./Apr. 2000), 90-1.
257. Davey, J., 'How safe are the birth control pills?', Redbook, Feb. 1963.
258. Davin, A., 'Imperialism and motherhood', History Workshop Journal, 5 (1978), 9-66.
259. De Lee, J., 'The prophylactic forceps operation', American Journal of Obstetrics and Gynecology, 1 (1920-1), 34-44, 77-84.
260. Deverell, C., 'The International Planned Parenthood Federation - its role in developing countries', Demography, 5/2, (1968), special issue, 574-7.
261. Devesa S. S. et al., 'Cancer incidence and mortality trends among whites in the United States, 1947-84', Journal of National Cancer Institute, 79 (1987), 701-70.
262. Diczfalusy, E., 'Gregory Pincus and steroidal contraception: a new departure in the history of mankind', Journal of Steroid Biochemistry, 11 (1979), 3-11.
263. Direcks, A. and Hoen, E., 'DES: The crime continues', in K. Donnell, ed., Adverse Effects: Women and the Pharmaceutical Industry (Toronto, 1986).
264. Djerassi, C., The Politics of Contraception (London, 1979).
265. Djerassi, C., The Pill, Pygmy Chimps, and Degas' Horse (New York, 1992).
266. Djerassi, C., 'Steroid research at Syntex: "The pill" and cortisone', Steroids, 57 (Dec. 1992), 631-41.
267. Djerassi, C., From the Lab into the World (Washington DC, 1994).
268. Djerassi, C., 'The mother of the pill', Recent Progress in Hormone Research, 50 (1995), 1-18.
269. Draper, E., Birth Control in the Modern World (Harmondsworth, 2nd edn, 1972).
270. Drill, V. A., 'History of the first oral contraceptive', Journal of Toxicology and Environmental Health, 3 (1977), 133-8.
271. Dunnell, K., Family Formation (London, 1976).
272. Dutt, R. H. and Casida, L. E., 'Alteration of estrual in sheep by use of progesterone and its effects upon subsequent ovulation and fertility', Endocrinology, 43 (1943), 208-217.
273. Dutton, D. B., Worse than the Disease: Pitfalls of Medical Progress (Cambridge, 1988).
274. Economist Intelligence Unit, 'Special Report no. 1: Contraceptives', Retail Business Market Surveys, no. 138 (Aug. 1969), 12-27.
275. Edgren, R. A., 'Early oral contraceptive history: Norethynodrel is not a prohormone', letter to the editor, Steroids, 59 (Jan. 1994), 58-9.
276. Editorial, 'Oral contraceptives: The good news', JAMA, 249/12 (25 Mar. 1983), 1624-5.
277. 'Editorial: Paying for family planning', Lancet, 352 (12 Sept. 1998), 831.
278. Edmonsen, H. A., Henderson, B. and Benton, B., 'Liver-cell adenomas associated with the use of oral contraceptives', New England Journal of Medicine, 294 (1976), 470-2.
279. Ehrenstrom, P., 'Eugenics and the law in Switzerland', Galton Institute Newsletter (Sept. 1997). 4-5.
280. Elkas J. and Farias-Eisner, R., 'Cancer of the uterine cervix', Current Opinion, Obstetrics and Gynecology, 10 (1998), 47-50.
281. Encyclopedia of Chemical Technology, 3rd edn (New York, 1978-84), vol. 6.
282. Encyclopedia of Chemical Technology, 4th edn (New York, 1991-8), vol. 7.
283. Engelmann, G. J., Labour among Primitive Peoples (St Louis, Ind., 1882).
284. Ernster, V. L., 'The epidemiology of benign breast disease', Epidemiological Reviews, 3 (1981), 184-202.
285. 'Experimental interruption of pregnancy', BMJ (10 Sept. 1938), 580.
286. Farmer, R. D. T. and Preston, T. D., 'The risk of venous thromboembolism associated with low oestrogen oral contraceptives', Journal of Obstetrics and Gynaecology, 15 (1995), 195-200.
287. Fasal, E. and Paffenberger, R. S., 'Oral contraceptives as related to cancer and benign lesions of the breast', JNCI, 55/4 (Oct. 1975), 767-73.
288. 'Fertility and contraception in 12 developed countries', Family Planning Perspectives, 13/3 (Mar./Apr. 1981), 93-103.
289. 'Fertility and infertility', transcript of a panel meeting, Bulletin of New York Academy of Medicine, 37/10 (Oct. 1961), 689-712.
290. Forrest, J. D., 'The delivery of family planning services in the United States', Family Planning Perspectives, 20/2 (1988), 88-95.
291. Fortes J. and Adler Lomnitz, L., Becoming a Scientist in Mexico: The Challenge of Creating a Scientific Community in an Underdeveloped Country, trans. A. P. Hynds, (Philadelphia, 1994).
292. Fortney, J. A., Harper J. M. and Potts, M., 'Oral contraceptives and life expectancy', Studies in Family Planning, 17/3 (May/June 1986), 117-25.
293. FPA, 'Joint statement on oral contraception and breast cancer', 20 Nov. 1987.
294. Fryer, P., The Birth Controllers (London, 1967).
295. Galewitz, P., '"The Pill" might prevent acne too', 30 Jan. 2000, Associated Press, Yahoo, http://biz.com.apf/000130/ the_pill_3.html.
296. Gardner, W. U., 'Tumors in experimental animals receiving steroid hormones', Surgery, 16 (1944), 8-32.
297. Gardner, W. U., 'Studies on steroid hormones in experimental carcinogenesis', Recent Progress in Hormone Research, 1 (1946), 217-60.
298. Garnall, D., 'Controversy rages over new contraceptive data', BMJ, 311, (28 Oct. 1995), 1117-18.
299. General Household Survey (London, 1983).
300. General Register Office, Registrar General's Statistical Review of England and Wales, part 1 (London, 1969).
301. Ghosh, S. and Gupta, A., 'The effectiveness as an oral contraceptive of synthetic metax/ylohydroquinone, the active principle of the field pea (Pisum Sativum Linn): A preliminary report', International Medical Abstracts and Reviews (16 Nov. 1954), 89-90.
302. Gillmer, M. D. G., 'Metabolic effects of combined oral contraceptives', in M. Filshie and J. Guillebaud, eds, Contraception: Science and Practice (London, 1989).
303. Glantz, L. H., 'The influence of the Nuremberg Code on U.S. statutes and regulations', in G. J. Annas and M. A. Grodin, eds, The Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation (Oxford, 1992).
304. Goldzeiher, J. W., 'Estrogens in oral contraceptives: historical perspectives', Johns Hopkins Medical Journal, 150 (1982).
305. Goldzieher, J. W., 'The history of steroidal contraceptive development: The estrogens', Perspectives in Biology and Medicine, 36/3 (Spring 1993), 363-8.
306. Goldzieher, J. W., 'Are low-dose oral contraceptives safer and better?', AJOG, 171/3 (Sept. 1994), 587-90.
307. Goldzieher, J. W., Moses, L. E. and Ellis, L. T., JAMA, 180 (1962), 352.
308. Goodman L. S. and Gilman, A., The Pharmacological Basis of Therapeutics, 2nd edn (New York, 1960).
309. Gordon, L., Woman's Body, Woman's Right: A Social History of Birth Control in America (New York, 1976).
310. Gossel, P. P. 'Packaging the pill', in R. Bud, ed., Manifesting Medicine: Bodies and Machines (Amsterdam, 1999), 105-22.
311. Gould, S. J., The Mismeasure of Man (London, 1992).
312. Grant, L., Sexingthe Millennium (London, 1993).
313. Grant, N. J., The Selling of Contraception: The Dalkon Shield Case, Sexuality, and Women's Autonomy (Columbus, Ohio, 1992).
314. Graves, R., Greek Myths (Wakefield, R.I., 1988).
315. Gray, M., Margaret Sanger. A Biography of the Champion of Birth Control (New York, 1979).
316. Greenblatt, E. R., et al., 'Breast cancer in mothers given diethylstilboestrol in pregnancy', New England Journal of Medicine, 311 (1984), 1393-7.
317. Greep, R. O., ed., Human Fertility and Population Problems (New York, 1963).
318. Greer, G., The Change: Women, Ageing and the Menopause (London, 1993).
319. Grigg, D., The World Food Problem (Oxford, 1993).
320. Grimes, D., 'The safety of oral contraceptives: Epidemiological insights from the first 30 years', AJOC, 166/6 (June 1992), part 2,1950-4.
321. Guillebaud, J., The Pill (Oxford, new edn 1991).
322. Guillebaud, J., 'Advising women on which pill to take', BMJ, 311 (28 Oct. 1995), 1111-12.
323. Gurewich, V. et al., 'Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with different progestagen components', Lancet, 346 (1995), 1589-93.
324. Halberstam, D., The Fifties (New York, 1993).
325. Hall, L., 'Women, feminism and eugenics', in R. Peel, ed., Essays in the History of Eugenics (London, 1998), 36-51.
326. Hall, L., '"A suitable job for a woman?": Women doctors and birth control before 1950', in L. Conrad and A. Hardy, eds, Women and Modern Medicine (Amsterdam, 2000).
327. Hall, L., 'Malthusian mutations: The changing politics and moral meanings of birth control in Britain', in B. Dolan, ed., Malthus, Medicine and Morality: 'Malthusianism' after 1798 (Amsterdam, 2000), 141-63.
328. Hancock and Co. Ltd, The Ravages of Time Defied: A Handbook of English, Foreign and Continental Animal Gland Prescriptions (London, 1934).
329. Hardon, A. P., 'Needs of women versus the interests of family planning personnel, policy-makers and researchers: Conflicting views on safety and acceptability of contraceptives', Social Science and Medicine, 35 (1992), 753-66.
330. Harkavy, O., Curbing Population Growth: An Insider's Perspective on the Population Movement (New York, 1995).
331. Harris, R., The Real Voice (New York, 1964).
332. Hartmann, B., Reproductive Rights and Wrongs: The Global Politics of Population Control (Boston, 1995).
333. Harvey Young, J., The Toadstool Millionaires: A Social History of Patent Medicines in America before Federal Regulation (Princeton, 1961).
334. Hawkins, D. F., 'Thromboembolic risks in contraception', Spectrum (newspaper of Family Planning and Human Conservation, published for Ortho Pharmaceutical Ltd), no. 1, 1973.
335. Hennekens C. H. et al., 'A case-control study of oral contraceptive use and breast cancer', JNCI, 72/1 (Jan. 1984), 39-42.
336. Henshaw, P. S., 'Physiologic control of fertility', Science, 117 (29 May 1953), 572-82.
337. Henzl, M. R., letter to editor, Lancet, 347 (27 Jan. 1996), 257-8.
338. Hertz, R., 'Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives', International Journal of Fertility, 13 (Oct./Dec. 1968), 273-86.
339. Hertz, R. and Bailar, J. C., 'Estrogen-progestogen combinations for contraception', JAMA, 198 (Nov. 1966), 136-42.
340. Hertz, R., Waite, J. H., and Thomas, L. B., 'Progestational effectiveness of 19-nor-ethinyl-testosterone by oral route in women', Proceedings of Experimental Biology and Medicine, 91 (1956), 418-20.
341. Hertz, R. et al, 'Observations on the effect of progesterone on carcinoma of the cervix', JNCI, 11 (Apr. 1951), 867-75.
342. Hodges, A., Alan Turing: The Enigma of Intelligence (London, 1983).
343. Hope, S., '12 per cent of women stopped taking their pill immediately they heard CMS's warning', letter, BMJ, 312 (1996), 576.
344. Horvath, E., Kovacs, K. and Ross, R. C., 'Ultrastructural findings in a well differentiated hepatoma', Digestion, 7 (1972), 74.
345. 'How safe are the birth control pills?', Vogue, 8 Jan. 1961, 90-1, 128.
346. Hubacher, D. and Potter, L., 'Adherence to oral contraceptive regimens in four countries', International Family Planning Perspectives, 19/2 (June 1993), 49-53.
347. Huggins, G. R. and Giuntoli, R. L., 'Oral contraceptives and neoplasia', Fertility and Sterility, 32/1 (July 1979), 1-23.
348. Humphries, S., A Secret World of Sex (London, 1991).
349. Hunt, K., 'The first pill-taking generation: past and present use of contraception amongst a cohort of women born in the early 1950s', British Journal of Family Planning, 16 (1990), 3-15.
350. Hunt, K. and Annandale, E., 'Predicting contraceptive method usage among women in West Scotland', Journal of Biosocial Science, 22/4 (1990), 405-21.
351. Huxley, A., Brave New World (London, 1994).
352. Inman, W. H. W., 'Role of drug-reaction monitoring in the investigation of thrombosis and "the pill"', British Medical Bulletin, 26/3 (1970), 248-56.
353. Inman, W. H. W. and Vessey, M. P., 'Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age', BMJ, 2 (27 Apr. 1968), 193-211.
354. Inman, W. H. W., Vessey, M. P., Westerholm, B. and Engelund, A., 'Thromboembolic disease and the steroidal content of oral contraceptives', BMJ, 2 (25 Apr. 1970), 203-9.
355. 'Is the pill too dependent on wild yams?', New Scientist (3 May 1973), 281.
356. Iverson, O. and Nilsen, S., 'Abortions increased by nearly 8 per cent in Norway', letter, BMJ, 313 (1996), 363-4.
357. Jackson, C. O., Food and Drug Legislation in the New Deal (Princeton, 1970).
358. Jackson, H., 'Antifertility substances', Pharmacological Reviews, 2 (1959), 135-72.
359. Jick, S. S. et al., 'Oral contraceptives and breast cancer', British Journal of Cancer, 59 (1989), 618.
360. Johnson, R. C., 'Feminism, philanthropy and science in the development of the oral contraceptive pill', Pharmacy in History, 19/2 (1977), 63-77.
361. Johnson, S. P., World Population and the United Nations: Challenge and Response (Cambridge, 1987).
362. Jones, E. F., Beninger J. R., and Westoff, C. F., 'Pill and IUD discontinuation in the United States, 1970-1975: The influence of the media', Family Planning Perspectives, 12/6 (1980), 293-300.
363. Jones E. F. et al., 'Unintended pregnancy, contraceptive practice and family planning services in developed countries', Family Planning Perspectives, 20/2 (Mar./Apr. 1988), 53-67
364. Jordanova, L., Sexual Visions: Images of Gender in Science and Medicine between the Eighteenth and Twentieth Centuries (London, 1989).
365. Junod, S. W. and Marks, L. V., 'Women on trial: approval of the first oral contraceptive in the United States and Great Britain', forthcoming.
366. Kaiser, R. B. The Encyclical that Never Was: The Story of the Pontifical Commission on Population, Family and Birth (London, 1987).
367. Kalache, A. et al., 'Oral contraceptives and breast cancer', British Journal of Hospital Medicine (Oct. 1983), 278-84.
368. Katz, H., 'British jump gun on pill data', Montreal Gazette, 21 Oct. 1995.
369. Kay, C. R., 'Oral contraceptives and cancer', letter to the editor, Lancet (29 Oct. 1983), 1018.
370. Kay, C. R., 'Latest views on Pill prescribing', Journal of the Royal College of General Practitioners (Nov. 1984), 611-14.
371. Kennedy, D. M., Birth Control in America: The Career of Margaret Sanger (New Haven, 1970).
372. Ketting, E., 'The "Dutch model" of family planning', International Health Foundation Newsletter, no. 3 (1992), 2-4.
373. Ketting, E., 'CMS's advice will harm women's health world-wide', letter, BMJ, 312 (1996), 576.
374. Ketting, E., and Visser, A. P. 'Contraception in the Netherlands: The low abortion rate explained', Patient Education and Counselling, 23 (1994), 161-71.
375. Kevles, D., In the Name of Eugenics: Genetics and the Uses of Human Heredity (Los Angeles, 1985).
376. Kiernan, K., Land, H. and Lewis, J., Lone Motherhood in Twentieth-Century Britain (Oxford, 1998).
377. Kleinman, R. L., Directory of Hormonal Contraceptives (Carnforth, Lanes., 1992).
378. Klopper, A., 'Advertisement and classification of oral contraceptives', BMJ (16 Oct. 1965), 932-3.
379. Kostering, S., 'Etwas Besseres als das Kondom', in G. Staupe and L. Vieth, eds, Die Pille: Von der Lust und von der Liebe (Berlin, 1996).
380. Kuhl, S., The Nazi Connection: Eugenics, American Racism and German National Socialism (Oxford, 1994).
381. Lader, L., The Margaret Sanger Story and the Fight for Birth Control (New York, 1955).
382. Langford, C. M., Birth Control Practice and Marital Fertility in Great Britain (Oxford, 1976).
383. Laqueur, T., Making Sex: Body and Gender from the Greeks to Freud (Cambridge, Mass., 1990).
384. Laurence, J., 'More bad news for the Pill', New Society, 22/29 (Dec. 1983), 50.
385. Leathard, A., The Fight for Family Planning (London, 1980).
386. Leavitt, J., 'Joseph DeLee and the practice of preventive obstetrics', American Journal of Public Health, 78/10 (1988), 1353-9.
387. Lederer, S. E., Subjected to Science: Human Experimentation in America before the Second World War (Baltimore, 1995).
388. Lee, L. T., 'Law and family planning', Studies in Family Planning (Population Council), 2, no.2 (Apr. 1971), 81-98.
389. Lehmann, P. A., Bolivar A. and Quinteron, R., 'Russell E. Marker: pioneer of the Mexican steroid industry', Journal of Chemical Education, 50/3 (Mar. 1973), 195-9.
390. Leis, H. P., 'Endocrine prophylaxis of breast cancer with cyclic estrogen and progesterone', International Surgery, 45/5 (May 1966), 496-503.
391. Lewis, M. A., 'The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young women', AJOG, 179/4 (Oct. 1998), 1086-97.
392. Lilienfeld, A., 'Epidemiology of infectious and non-infectious disease: some comparisons', American Journal of Epidemiology, 97 (1973), 135-47.
393. Lincoln, R., 'The pill, breast and cervical cancer, and the role of progestogens in arterial disease', Family Planning Perspectives, 16/2 (Mar./Apr. 1984), 55-63.
394. Lipnick, R. J., 'Oral contraceptives and breast cancer: A prospective cohort study', JAMA, 255/1 (3 Jan. 1986), 58-61.
395. Lippincott, J. P. and Co., New and Nonofficial Remedies (Philadelphia, 1951).
396. Loudon, I., Deaths in Childbirth: An International Study of Maternal Care and Maternal Mortality 1800-1950 (Oxford, 1992).
397. Loudon, I., 'Some international features of maternal mortality, 1880-1950', in V. Fildes, L. V. Marks and H. Marland, eds, Women and Children First: International Maternal and Infant Welfare, 1870-1945 (London, 1992).
398. 'Lower-dose pills', Population Reports, Series A, no. 7 (Nov. 1988), 1-31.
399. Luker, K., Taking Chances: Abortion and the Decision Not to Contracept (Berkeley, 1975).
400. McCann, C. R., Birth Control Politics in the United States (Ithaca, 1994).
401. McCrea, F. B., and Markle, G. E., 'The estrogen replacement controversy in the USA and UK: Different answers to the same question?', Social Studies of Science, 14 (1984), 1-26.
402. McFadyen, R., 'Thalidomide in America: A brush with tragedy', Clio Medica, 11/2 (1976), 79-93.
403. McLaren, A., A History of Contraception: From Antiquity to the Present Day (Oxford, 1994).
404. McLaughlin, L., The Pill, John Rock, and the Catholic Church: The Biography of a Revolution (Boston, 1982).
405. MacMahon, B., Cole P. and Brown, J., 'Etiology of human breast cancer: a review', JNCI, 50 (1973), 21-42.
406. McNeill, P. M., The Ethics and Politics of Human Experimentation (Cambridge, 1993).
407. Macnicol, J., 'Eugenics and the campaign for voluntary sterilization in Britain between the wars', Social History of Medicine, 2/2 (Aug. 1989), 147-70.
408. McPherson, K., 'Modelling latent effects in any association between oral contraceptives and breast cancer', in H. Morgenstern et al., eds, Models of Non-Communicable Diseases: Health Status and Health Service Requirements (Heidelberg, 1992), 74-5.
409. McPherson, K. and Owen J., letters to the editor, British Medical Journal (20 Sept. 1986), 710.
410. McPherson K. et al., 'Oral contraceptives and breast cancer', Lancet, 2 (1983), 1414-15.
411. McPherson K. et al., 'Early oral contraceptive use and breast cancer: Results of another case-control study', British Journal of Cancer, 56 (1987), 653.
412. Maeder, T., Adverse Reactions (New York, 1994).
413. Maisel, A. Q., The Hormone Quest (New York, 1965).
414. Makepeace, A. W., Weinstein, C. L. and Friedman, M. H., 'The effect of progestin and progesterone on ovulation in the rabbit', American Journal of Physiology, 119 (1937), 512-16.
415. Mann C. C. and Plummer, M. L., The Aspirin Wars: Money, Medicine, and One Hundred Years of Rampant Competition (New York, 1991).
416. Mann, R. D., 'Breast cancer risk and the administration of human hormones: Part 1. Hormone replacement therapy', Adverse Drug Reaction Toxicology Review, 11/3 (1992), 149-72.
417. Marks, H. M., 'Cortisone, 1949: A year in the political life of a drug', Bulletin of the History of Medicine 6/3 (1992), 419-40.
418. Marks, H. M., The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 (Cambridge, 1997).
419. Marks, L. V., 'Historical perspectives: The oral contraceptive pill and its controversies', British Journal of Sexual Medicine, 22/5 (Sept./Oct. 1995), 25-7.
420. Marks, L. V., 'Controversial contraception: The international history of the oral contraceptive pill', Wellcome Trust Review, 5 (1996), 51-3.
421. Marks, L. V. '"A 'cage' of ovulating females": The history of the early oral contraceptive pill clinical trials, 1950-59', in H. Kamminga and S. de Chadarevian, eds, Modularising Biology and Medicine, 19230s-1930s (Amsterdam, 1998), 221-47.
422. Marks, L. V., 'Human guinea pigs? The history of the early oral contraceptive clinical trials', History and Technology, 15 (1999), 1-26.
423. Marks, L. V., 'The migration of scientific knowledge in the making of the contraceptive pill', Proceedings of the American Historical Association, (1999), ref: 10485.
424. Marks, L. V., '"Not Just a Statistic": The history of USA and UK policy over thrombotic disease and the oral contraceptive pill, 1960S-1970S', Social Science and Medicine, 49 (1999), 1139-55.
425. Marks, L. V., 'Parenting the pill: The early testing of the contraceptive pill', in A. R. Saetnan, N. Oudshoorn and M. Kirejczyk, eds, Localizing and Globalizing Technologies (Ohio, 2000).
426. Marks, L. V., '"Andromeda freed from her chains": medical attitudes towards women and the pill, 1950-1970', in L. Conrad and A. Hardy, eds, Women and Modern Medicine, (Amsterdam, 2001).
427. Marks, L. V., '"Public-spirited and enterprising volunteers": The council for the investigation of fertility control and the British clinical trials of the oral contraceptive pill, 1959-1973', in M. Gijswijt-Hofstra and T. Tansey, eds, Remedies and Healing Cultures in Britain and the Netherlands in the Twentieth Century, (Amsterdam, 2001).
428. Martin, E., The Woman in the Body: A Cultural Analysis of Reproduction (Milton Keynes, 1987).
429. Martin, G., 'Phosphorylated hesperdin', Science, 117 (3 Apr. 1953), 363.
430. Maruyama, H., Raphael J. H., and Djerassi, C., 'Why Japan ought to legalize the pill', Nature, 379 (15 Feb. 1998), 579-80.
431. Mays, E. T. et al., 'Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors', JAMA, 235 (1976), 730-2.
432. Medical Research Council, 'Risk of thromboembolic disease in women taking oral contraceptives', BMJ, 2 (6 May 1967), 355-9.
433. Meirik, O. et al., 'Oral contraceptive use and breast cancer in young women: A joint national case-control study in Sweden and Norway', Lancet (20 Sept. 1986), 650-3.
434. Melamed M. R. et al.,'Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids', BMJ, 3 (1969), 195-200.
435. Meldrum, M., '"Simple Methods" and "Determined Contraceptors": The statistical evaluation of fertility control, 1957-1968', Bulletin for the History of Medicine, 70 (1996), 266-95.
436. 'Microbes may replace yams for making the pill', New Scientist (5 Sept. 1974), 589.
437. Miller, D. R. et al., 'Breast cancer risk in relation to early oral contraceptive use', Obstetrics and Gynecology, 68/6 (Dec. 1986), 863-8.
438. Millman N. and Rosen, F., 'Failure of phosphorylated hesperidin to influence fertility in rodents', Science, 118 (21 Aug. 1953), 212-13.
439. Mintz, M., "The pill, press and public at the experts' mercy', Columbia Journalism Review (Winter 1968-9), 4-10.
440. Moore, F. D., 'Ethical boundaries in initial clinical trials', in P. A. Freund, ed., Experimentation with Human Subjects (New York, 1970).
441. Morgenstern, H. et al., eds, Models of Non-Communicable Diseases: Health Status and Health Service Requirements (Heidelberg, 1992).
442. Moscucci, O., The Science of Woman: Gynaecology and Gender in England, 1800-1929 (Cambridge, 1990).
443. Mosher, W., 'Fertility and family planning in the 1970s: The national survey of family growth', Family Planning Perspectives, 14/6 (1982), 314-20.
444. Mumford, S. D., 'The Vatican and world population policy: An interview with Milton P. Siegel' on http://www.kzpg.com/Lib/Pages/Books/NSSM-200/29-APP3.html
445. Murphy, M., 'The contraceptive pill and women's employment as factors in fertility change in Britain 1963-1980: A challenge to the conventional view', Population Studies, 47 (1993), 221-43.
446. Murphy, M., 'Sterilisation as a method of contraception: Recent trends in Great Britain and their implications', Journal of Biosocial Science, 27 (1995), 31-46.
447. Murray C. J. L. and Lopez, A. D., eds, Global Health Statistics, Global Burden of Disease and Injury Series, vol. 2, Harvard School of Public Health on behalf of WHO and the World Bank (Boston, 1996).
448. Murty, J. and Firth, S., 'Contraceptive effectiveness may be being sacrificed for safety', letter, BMJ, 313 (1996), 363.
449. Nash, M., 'Pronatalism and motherhood in Franco's Spain', in G. Bock and P. Thane, eds, Maternity and Gender Policies, (London, 1991), 160-77.
450. National Science Foundation, Technology in Retrospect and Critical Events in Science, vol.1 (15 Dec. 1968) and vol. 2 (30 Jan. 1969).
451. Newhouse, M. L. et al., 'A case-control study of carcinoma of the ovary', British Journal of Preventive Social Medicine, 31 (1977), 148-53.
452. NHS Centre for Reviews and Dissemination, 'Preventing and reducing the adverse effects of unintended teenage pregnancies', Effective Health Care, 3/1 (Feb. 1997), 1-12.
453. 'OCs - update on usage, safety, and side effects', Population Reports, Series A, no. 5 (Jan. 1979).
454. Offen, K., 'Body politics: women, work and the politics of motherhood in France, 1920-1950', in G. Bock and P. Thane, eds, Maternity and Gender Policies (London, 1991).
455. Office of Health Economics, Family Planning in Britain (London, 1972).
456. Ohlander, A. S., 'The invisible child? The struggle for a Social Democratic family policy in Sweden, 1900-1960S', in G. Bock and P. Thane, eds, Maternity and Gender Policies (London, 1991).
457. 'Oral contraceptives', Population Reports, Series A, No. 2 (Mar. 1975).
458. 'Oral contraceptives - 50 million users', Population Reports, Series A, no. 1 (Apr. 1974).
459. 'Oral contraceptives in the 1980s', Population Reports, Series A, 10/3 (May-June 1982).
460. Ory, H. W., Making Choices: Evaluating the Health Risks and Benefits of Birth Control Methods (New York, 1983).
461. Oudshoorn, N., Beyond the Natural Body: An Archaeology of Sex Hormones (London, 1994).
462. Ovid, Metamorphoses Book IV, trans. R. Graves (Cambridge, Mass., 1985).
463. Paffenberger, R. S. et al., 'Cancer risk as related to use of oral contraceptives during fertile years', Cancer, 39 (1977), 1887-91.
464. Parkes, A. S., 'The Biology of Fertility', in Greep, R. O., ed., Human Fertility and Population Problems (New York, 1963).
465. Parkes, A. S., Dodds, E. S. and Noble, R. L., 'Interruption of early pregnancy by means of orally active oestrogens', BMJ (10 Sept. 1938), 557-8.
466. Parkin, D. M., Laara, E. and Muir, C. S., 'Estimates of worldwide frequency of sixteen major cancers in 1980', International Journal of Cancer, 41 (1988), 184-97.
467. Paul, C., Skegg, D. C., and Spears, G. F. C., 'Oral contraception and breast cancer in New Zealand', in R. D. Mann, ed., Oral Contraceptives and Breast Cancer (Carnforth, Lanes, 1990), 85-94.
468. Paul C. et al., 'The pill and breast cancer: why the uncertainty?', letter to editor, BMJ, 293/29 Nov. 1986, 1433.
469. Payer, L., Medicine and Culture: Notions of Health and Sickness (London, 1989).
470. Pedro, A. and Lehmann, P. A., 'Early history of steroid chemistry in Mexico: The story of three remarkable men', Steroids, 57 (Aug. 1992), 403-8.
471. Pedro, A. et. al., 'Russell E. Marker: Pioneer of the Mexican steroid industry', Journal of Chemical Education, 50/3, (3 Mar. 1973), 198.
472. Peel, J. and Potts, M., Textbook of Contraceptive Practice (Cambridge, 1969).
473. Perley, S., Fluss, S. S., Bankowski, Z. and Simon, F., 'The Nuremberg Code: An international overview', in G. J. Annas and M. A. Grodin, eds, The Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation (Oxford, 1992).
474. 'Permission denied', Far Eastern Economic Review (14 Apr. 1994), 38.
475. Perone, N., 'The history of steroidal contraceptive development: The progestins', Perspectives in Biology and Medicine, 36/3 (Spring 1993), 347-68.
476. Peterson, L., 'Contraceptive use in the United States: 1982-90'. Advance Data (Centers for Disease Control and Prevention), no. 260 (14 Feb. 1995), 1-16.
477. Peto, J., 'Oral contraceptives and breast cancer: Is the CASH study really negative?', Lancet, 1 (1989), 552.
478. Pfeffer, N., 'Lessons from history: The salutary tale of stilboestrol', in P. Alderson, ed., Consent to Health Treatment and Research: Differing Perspectives, Report of the Social Science Research Unit Consent Conference Series, no. 1 (Dec. 1992).
479. Pfeffer, N., The Stork and the Syringe (Cambridge, 1993).
480. Piccino L. J., and Mosher, W. D., 'Trends in contraceptive use in the United States: 1982-1995', Family Planning Perspectives, 30/1 (Jan./Feb. 1998), 4-10.
481. Pike, M. C. et al., 'Oral contraceptive use and early abortion as risk factors for breast cancer in young women', British Journal of Cancer, 43 (1981), 72-6.
482. Pike, M. C. et al., 'Breast cancer in young women and use of oral contraceptives; Possible modifying effect of formulation and age at use', Lancet, 2 (1983), 926-30.
483. 'Pill pariah', In These Times (7 Aug. 1995), 10-11.
484. 'Pill scares and public responsibility', Lancet, 347 (22 June 1996), 1707.
485. Pincus, G., 'Factors controlling the growth of rabbit blastocysts', American Journal of Physiology, 133 (1941), 412-13.
486. Pincus, G., "The physiology of ovarian hormones', The Hormones, 2 (1950).
487. Pincus, G., 'Fertilization in mammals', Scientific American, 184/3 (1951).
488. Pincus, G. 'Progestational agents and the control of fertility,' Vitamins and Hormones, 169 (1959), 81.
489. Pincus, G., The Control of Fertility (New York, 1965).
490. Pincus, G., 'Control of contraception by hormonal steroids', Science, 153 (19 July 1966), 493-500.
491. Pincus, G. and Garcia, C. R., 'Studies in vaginal, cervical and uterine histology', Metabolism, 3 (1965), 344-7.
492. Pincus, G. and Kirsch, R. E., 'The sterility in rabbits produced by injections of oestrone and related compounds', Journal of Experimental Physiology, 115 (1936), 219-28.
493. Pincus G. and Werthenssen, N. T., 'The comparative behaviour of mammalian eggs in vivo and in vitro. III. Factors controlling the growth of the rabbit blastocyst', Journal of Experimental Zoology, 78 (1938), 1-18.
494. Pincus G. and Werthenssen, N. T., 'An analysis of the mechanism of oestrogenic activity', Proceedings of the Royal Society, 126 (1939), 506.
495. Pincus, G., Rock, R. and Garcia, C. R., 'Field trials with norethynodrel as an oral contraceptive', Report of the Proceedings of the Sixth International Conference on Planned Parenthood, 14-21 Feb. 1959, New Dehli, India.
496. Pincus, G. et al., 'Fertility control with oral medication', AJOG, 75 (June 1958), 1333-46.
497. Piotrow, P., World Population Crisis: The United States Response (New York, 1973).
498. Piper J. M. and Kennedy, D. L., 'Oral contraceptives in the United States: Trends in content and potency', International Journal of Epidemiology, 16/2 (1987), 215-21.
499. Pollock, S., 'Refusing to take women seriously: Side effects and the politics of contraception', in R. Arditti et al., eds, Test-Tube Women: What Future for Motherhood? (London, 1984), 148-51.
500. Pope Paul VI, Humanae Vitae, Encyclical of Pope Paul VI on the Regulation of Birth, 25 July 1968, CM 66 (Sept. 1968).
501. Potts, M., 'Birth Control Methods in the United States', Family Planning Perspectives, 20/6 (Nov./Dec. 1988), 268-97.
502. Pratt W. F. and Bachrach, C. A., 'What do women use when they stop using the pill?', Family Planning Perspectives, 19/6 (1987), 257-66.
503. Prentice, R. L. and Thomas, D. B., 'On the epidemiology of oral contraceptives and disease', Advances in Cancer Research, 19 (1987), 342-59.
504. President's Advisory Committee, The Human Radiation Experiments: Final Report of the President's Advisory Committee (New York, 1996).
505. Proctor, R., Racial Hygiene: Medicine under the Nazis (Cambridge, Mass., 1989).
506. Ramcharan, S., ed., The Walnut Creek Contraceptive Drug Study: A Prospective Study of the Side-Effects of Oral Contraceptives, Vol. 1 (Washington DC, 1974).
507. Ramirez de Arellano, A. B. and Seipp, C., Colonialism, Catholicism and Contraception: A History of Birth Control in Puerto Rico (London, 1983).
508. Ravenholt, R. T., 'The A.I.D. population and family planning program - goals, scope and progress', Demography, 5/2 (1968).
509. Ray, J., and Gosling, F. G., 'American physicians and birth control, 1936-47', Journal of Social History, 18 (1985), 399-411.
510. Reed, J., The Birth Control Movement and American Society: From Private Vice to Public Virtue (Princeton, 1984).
511. Report of the Committee of Enquiry into the Relationship of the Pharmaceutical Industry with the National Health Service, 1965-7, Cmnd. 3410 (London, 1967).
512. Rice-Wray, E., Becerra, C., Esquivel J. and Maqueo, M., 'Clinical trials of a combination of lynestrenol and menstranol (lyndiol) as an oral contraceptive agent', Canadian Medical Association Journal, 9 (12 Nov. 1966), 1024-30.
513. Richart, R. M., 'Cervical cancer in developing countries', in Special Challenges in Third World Women's Health, presentations at the 1989 annual meeting of the American Public Health Association, published at http://www.iwhc.org/sc_cc.html.
514. Ridker, P. M., Miletich, J. P., Hennekens, C. H., and Buring, J. E., 'Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening.' Journal of the American Medical Association, 277/16 (23-30 Apr. 1997), 1305-7.
515. Roberts, D., 'Black women and the pill', Family Planning Perspectives, 32/2 (Mar./Apr. 2000), 92-3.
516. Rock, J., 'Medical and biological aspects of contraception', Clinics, 1 (Apr. 1943), 1601-2.
517. Rock, J., 'We can end the battle over birth control', Good Housekeeping, July 1961.
518. Rock, J., 'It is time to end the birth control fight', Saturday Evening Post, 20 Apr. 1963, 10,14.
519. Rock, J., The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control (New York, 1963).
520. Rock, J., 'Keynote address to Symposium on Progestogen-Estrogen Compounds', Applied Therapeutics, 6/5 (May 1964), 406-9.
521. Rock, J., 'Science and charity to the rescue of humanity', Pacific Medicine and Surgery (Ortho-Symposium), 73 (Feb. 1965), 1-A-25-27.
522. Rosenberg, L. et al., 'Breast cancer and oral contraceptive use', American Journal of Epidemiology, 119 (1984), 167.
523. Rosenkrantz, G., 'From Ruzicka's terpenes in Zurich to Mexican steroids via Cuba', Steroids, 57 (Aug. 1992), 409-18.
524. Royal College of General Practitioners, Oral Contraceptives and Health: An Interim Report from the Oral Contraception Study of the Royal College of General Practitioners (Oxford, 1974).
525. Rupke, R., ed., Vivisection in Historical Perspective (London, 1987).
526. Russel-Briefel, R., Ezzarati T. and Pelman, J., 'Prevalence and trends in oral contraceptive use in pre-menopausal females, ages 12-54, United States, 1971-1980', American Journal of Public Health, 75 (1985), 1173-6.
527. Salas, R. M., International Population Assistance: The First Decade (New York, 1979).
528. Sanger, M., The New Motherhood (London, 1922).
529. Sanger, M., The Pivot of Civilization (New York, 1922).
530. Sanyal, S. N., 'Functional uterine bleeding', Journal of Medicine and International Medical Abstract Review, 24/5 (1960), 5-11.
531. Sanyal, S. N., 'Ten years of research on an oral contraceptive from Pisum Sativum Linn', Science and Culture, 25 (June 1960), 661-5.
532. Sanyal, S. N. and Ghosh, S., 'Further clinical results with metaxylohydroquinone as an oral contraceptive', International Medical Abstracts and Reviews, 18/5 (Nov. 1955), 101-4.
533. Sartwell, P. E., Arthes, F. G. Tonascia, J. A., 'Epidemiology of benign breast lesions; Lack of association with oral contraceptive use', New England Journal of Medicine, 288 (1973). 551
534. Sax, K., 'The world's exploding population', Perspectives in Biology and Medicine, 7 (1963), 326-7.
535. Sayer, S. L. and Bausch, J. J. Towards Safe, Convenient and Effective Contraceptives: A Policy Perspective, Population Council (New York, 1978).
536. Schlesselman, J. J., et al., 'Breast cancer in relation to early use of oral contraceptives: No evidence of a latent effect', JAMA, 259/12 (25 Mar. 1988), 1828-33.
537. Schlesselman, J. J., 'Oral contraceptives and breast cancer', AJOG, 163/4, part 2 (Oct. 1990). 1379-87.
538. Schlesselman, J. J. et al., 'Breast cancer in relation to type of estrogen contained in oral contraceptives', Contraception, 36 (1987), 595.
539. Schrecker, E., The Age of McCarthyism: A Brief History with Documents (Boston, 1994).
540. Schwarz, R., 'FDA panel recommends limiting estrogen dose in contraceptives', Medical World News (14 Mar. 1988), 13.
541. Scrimshaw, S. M., 'Women and the pill: From panacea to catalyst', Family Planning Perspectives, 13/6 (Nov./Dec. 1981), 254-62.
542. Seaman, B., The Doctors' Case against the Pill (Alameda, Calif., 1995).
543. Seaman, B. and Seaman, G., Women and the Crisis in Sex Hormones (New York, 1977).
544. G. D. Searle and Co. Proceedings of a Conference: Thromboembolic Phenomena in Women (Chicago, 1962).
545. Second Reading of Colonial Development and Welfare Bill, Parliamentary Debates, House of Commons, 2 Feb. 1955.
546. Seigel, D. and Corfman, P., 'Epidemiological problems associated with studies of the safety of oral contraceptives', JAM A, 203/11 (11 Mar. 1963), 950-4.
547. Sen, A., 'Population: delusion and reality', New York Review of Books, 22 Sept. 1992, 1-7.
548. Sen, A., 'Population and reasoned agency: Food, fertility, and economic development', in K. Lindahl-Kiessling and H. Landberg, eds, Population, Economic Development and the Environment (Oxford, 1994), 52-5.
549. Shaw, R. W., 'Adverse long-term effects of oral contraceptives: A review', British Journal of Obstetrics and Gynaecology, 94 (Aug. 1987), 724-30.
550. Shen, L. and Dahlback, B., 'Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa', Journal of Biological Chemistry, 269/29 (22 July 1994), 18735-8.
551. Sherris, J. D., 'Cervical cancer prevention: A strategic opportunity to improve women's reproductive health', Family Planning Perspectives, 25 (Jan. 1999), supplement.
552. Sieve, B. F., 'A new antifertility factor (a preliminary report)', Science (10 Oct. 1952), 373-85.
553. Silverman J. and Jones, E. F., 'The delivery of family planning and health services in Great Britain', Family Planning Perspectives, 20/2 (Mar./Apr. 1988), 68-79.
554. Simmer, H. H., 'On the history of hormonal contraception I. Ludwig Haberlandt (1885-1932) and his concept of hormonal sterilization', Contraception, 1/1 (Jan. 1970), 3-27.
555. Simmer, H. H., 'On the history of hormonal contraception II. Otfried Otto Fellner (1873-n.d.) and estrogens as antifertility hormones', Contraception, 3/1 (Jan. 1971), 1-21.
556. Singh S. and Darroch, J. E., 'Trends in sexual activity among adolescent American women: 1982-1995', Family Planning Perspectives, 31/5 (Sept./Oct. 1999), 212-19.
557. Sjostrom, H. and Nilsson, R., Thalidomide and the Power of the Drug Companies (Harmondsworth, 1972).
558. Skegg, D. C. G., 'Risks and benefits of oral contraceptives: Will breast cancer tip the balance?', in Institute of Medicine, Oral Contraceptives and Breast Cancer (Washington, 1991).
559. Skouby, S. O., 'Oral contraceptives and venous thrombosis: End of the debate?' European Journal of Contraception and Reproductive Health Care, 3/2 (June 1998), 59-64.
560. Sneader, W., Drug Discovery: The Evolution of Modern Medicines (Chichester, N.Y., 1985).
561. Sneader, W., Drug Prototypes and their Exploitation, (Chichester, N.Y., 1996).
562. Snider, S., 'The pill: 30 years of safety concerns', FDA Consumer, 24/10 (1990), 8-11.
563. Soloway, R. A., Demography and Degeneration: Eugenics and the Declining Birthrate in Twentieth Century Britain (Chapel Hill, N.C., new edn. 1995).
564. Spencer, S. M., 'The birth control revolution', Saturday Evening Post, 15 Jan. 1966, 21-5, 66-70.
565. Spitzer, W. O., 'The 1995 pill scare revisited: Anatomy of a non-epidemic', Human Reproduction 12/11 (Nov. 1997), 2347-57.
566. Spitzer, W. O. et al., 'Third generation oral contraceptives and risks of venous thromboembolic disorders: an international case-control study', BMJ, 312 (13 Jan. 1996), 83-8.
567. Stadel, B. V. et al, 'Oral contraceptives and breast cancer in young women', Lancet (2 Nov. 1985), 970-3.
568. Stanford, J. L., 'Oral contraceptives and neoplasia of the ovary', Contraception, 43/6 (1991). 543-56.
569. Stepan J. and Kellogg, E. H., The World's Laws on Contraceptives, Law and Population Monograph Series, no. 17 (Medford, Mass., 1974).
570. Stepan, N., The Hour of Eugenics: Race, Gender and Nation in Latin America (Ithaca, 1991).
571. Stockley, I. 'Drugs in use: Interactions with oral contraceptives', Pharmaceutical Journal, 1 (1976), 140-3.
572. Stolley, P. D., Schapiro, S., Sloane, D. and Schinnar, R., 'Cardiovascular effects of oral contraceptives', Southern Medical Journal, 71/7 (July 1978), 821-4.
573. Stone, A., 'The teaching of contraception in medical schools', Human Fertility, 7 (Aug. 1942), 108.
574. Stopes, M., Enduring Passion (London, 1928).
575. Stourton, E., Absolute Truth: The Catholic Church in the World Today (London, 1999).
576. Sturtevant, F. M., 'Breast cancer and oral contraceptives: Critique of the proposition that high potency progestogen products cover excess risk', Biomedicine and Pharmacotherapy, 38 (1984), 371-9.
577. Suissa, S. et al., 'First-time use of newer oral contraceptives and the risk of venous thromboembolism', Contraception, 56/3 (Sept. 1997) 114-6.
578. Surface, B., 'Controversy over "the pill"', Good Housekeeping, Jan. 1970, 64-5, 123-7.
579. Susser, M., 'Epidemiology in the United States after World War II: Evolution of technique', Epidemiologic Reviews 7 (1985), 147-77.
580. Syntex Corporation, A Corporation and a Molecule: The Story of Research at Syntex (Palo Alto, 1966).
581. Szarewski, A., 'New evidence of risk of VTE and combined oral contraceptives', Clinical Pulse (2 Sept. 2000), 53, 57, 61.
582. Szpilfogel, S. A. and Zeelen, F. J., 'Steroid research at Organon in the golden 1950s and the following years', Steroids, 61 (1996), 483-91.
583. Szreter, S., 'The ideas of demographic transition and the study of fertility change: A critical intellectual history', Population and Development Review, 19/4 (Dec. 1993), 659-701.
584. Taylor, T. 'Opening statement of the prosecution December 9, 1946', in G. J. Annas and M. A. Grodin, eds, The Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation (Oxford, 1992).
585. Temin, P., Taking your Medicine: Drug Regulation in the United States (Cambridge, Mass., 1980).
586. Thomas, D. B., 'Do hormones cause breast cancer?', Cancer, 53 (1 Feb. 1984), supplement, 595-601.
587. Thomas, J. D. and Williams, S., 'Women and abortion in 1930s Britain: A survey and its data', Social History of Medicine, 11/2 (1988), 283-310.
588. Thorogood, M. and Vessey, M. P., 'Trends in use of oral contraceptives in Britain', British Journal of Family Planning, 16 (1990), 41-53.
589. Thorogood, M. and Villard-Mackintosh, L., 'Combined oral contraceptives: Risks and benefits', British Medical Bulletin, 49/1 (1993), 124-39.
590. Tone, A., 'Contraceptive consumers: Gender and the political economy of birth control in the 1930s', Journal of Social History, 29/3 (1996), 485-506.
591. Torres, A. and Jones, E. F., 'The delivery of family planning services in the Netherlands', Family Planning Perspectives, 20/2 (Mar./Apr. 1988), 75-9.
592. Tullner, W. M., and Hertz, R., 'High progestational activity of 19-norprogesterone', Endocrinology, 52 (1953), 359-60.
593. Tullner, W. M. and Hertz, R., 'Progestational activity of 19-norprogesterone and 19-norethisterone in the rhesus monkey', Proceedings of the Society of Experimental Biology and Medicine, 94 (1957), 298-300.
594. Turney, J., Frankenstein's Footsteps: Science, Genetics and Popular Culture (New Haven, 1998).
595. Tyler, E. T., 'Eight years' experience with oral contraceptives and an analysis of use of low-dosage norethisterone', BMJ (3 Oct. 1964), 843-7.
596. Tyler, E. T., 'Oral contraceptives', JAMA, 175 (1961), 225.
597. Tyler May, E., Homeward Bound: American Families in the Cold War Era (New York, 1988).
598. Tyrer, L. B. and Salas, J. E., 'Contraceptive problems unique to the United States', Clinical Obstetrics and Gynaecology, 32/2 (June 1989), 307-15.
599. Ubell, E., 'Birth-control pill found effective', New York Herald Tribune, 28 May 1958.
600. UK National Case-control Study Group, 'Oral contraceptive use and breast cancer risk in young women', Lancet, 1 (1989), 973-82.
601. UN, Levels and Trends of Contraceptive Use as Assessed in 1994 (New York, 1996).
602. UN, Recent Levels and Trends of Contraceptive Use as Assessed in 1983 (New York, 1984).
603. Usbourne, C., The Politics of the Body in Weimar Germany (London, 1992).
604. Van de Kaa, D. J., 'Population prospects and population policy in the Netherlands', Netherlands Journal of Sociology, 17 (1981), 73-91.
605. Vaughan, P., The Pill on Trial (Harmondsworth, 1972).
606. Vaughan, P., 'The pill turns twenty', New York Times Magazine, 13 June 1976.
607. Vessey, M. P., 'Female hormones and vascular disease - an epidemiological overview', British Journal of Family Planning, Supplement, 6/1 (Oct. 1980), 1-12.
608. Vessey, M. P., 'Oral contraceptives and breast cancer', IPPF Medical Bulletin, 21/6 (Dec. 1987), 1-2.
609. Vessey, M. P., 'Epidemiologic studies of oral contraception', International Journal of Fertility, Supplement, 34 (1989), 64-70.
610. Vessey, M. P. and Doll, R., 'Investigation of relations between use of oral contraceptives and thromboembolic disease: A further report', BMJ, 2 (14 June 1969), 651-7.
611. Vessey, M. P. and Doll, R., 'Evaluation of existing techniques: Is "the pill" safe enough to continue using?', Proceedings of the Royal Society of London, 195 (1976), 69-80.
612. Vessey, M. P. and Inman, W. H. W., 'Speculations about mortality trends from venous thromboembolic disease in England and Wales and their relation to the pattern of oral contraceptive usage', Journal of Obstetrics and Gynaecology of the British Commonwealth, 80 (June 1973), 562-6.
613. Vessey, M. P. and Mann, J. I., 'Female sex hormones and thrombosis: Epidemiological aspects', British Medical Bulletin, 34/2 (1978), 157-62.
614. Vessey, M. P., Doll R., and Sutton, P. M., 'Investigations of the possible relationship between oral contraceptives and benign and malignant breast disease', Cancer, 28 (1971), 1395.
615. Vessey, M. P., Doll, R. and Sutton, P. M., 'Oral contraceptives and breast neoplasia: A retrospective study', BMJ, 3 (1972), 719-34.
616. Vessey, M. P., Doll, R., Fairbairn A. S. and Glober, G., 'Postoperative Thromboembolism and the Use of Oral Contraceptives', BMJ, 3 (1970), 123-6.
617. Vessey, M. P., Villard-Mackintosh, L., McPherson, K. and Yeates, D., 'Mortality among contraceptive users: 20 year follow-up of women in a cohort study', BMJ, 299 (16 Dec. 1989), 1487-91.
618. Vessey, M. P. et al., 'A long term follow-up study of women using different methods of contraception: an interim report', Journal of Biosocial Science, 8 (1976), 373.
619. Vessey, M. P. et al., 'Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk', British journal of Cancer, 45 (1982), 327-31.
620. Vessey, M. P. et al., 'Oral contraceptives and breast cancer: Latest findings in a large cohort study', British Journal of Cancer, 59 (1989), 613-17.
621. Villar Borja, A., 'Productos Quimicos Vegetales Mexicanos, S.A. De C.V. (Proquivemex)', in X. Lozoya, Estado Actual Del Conocimeiento en Plantas Medicanas (Mexico City, 1976).
622. Vogt, W., The Road to Survival (New York, 1948).
623. Wall, M. E. et al., 'Steroidal Sapogenins. VII. Survey of plants for steroidal sapogenins and other constituents', Journal of the American Pharmaceutical Association: Scientific Edition, 43/1 (Jan. 1954), 1-7.
624. Watkins, E., On the Pill: A Social History of Oral Contraceptives, 1950-1970 (Baltimore, 1998).
625. Wellings, K., 'Help or hype: an analysis of media coverage of the 1983 "pill scare"', British Journal of Family Planning, 11 (1985), 92-8.
626. Wellings, K., 'Trends in contraceptive method usage since 1970', British Journal of Family Planning, 12 (1986), 57-64.
627. Westoff, L. A. and Westoff, C. F., From Now to Zero: Fertility, Contraception and Abortion in America (Boston, 1971).
628. 'What do consultants think of the pill?', World Medicine (27 Feb. 1968), 82-3.
629. WHO, Technology of Reproduction Series. World Health Organization (1966), no. 326.
630. WHO (collaborative study of neoplasia and steroid contraceptives), 'Epithelial ovarian cancer and combined oral contraceptives', International Journal of Epidemiology, 18 (1989), 538-45.
631. WHO, 'WHO publishes research findings on oral contraceptives and risk of venous thromboembolism', press release, WHO/92,15 Dec. 1995.
632. WHO (collaborative study of cardiovascular disease and steroid hormone contraception), 'Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease', Lancet, 364 (1995): 1582-8.
633. WHO, 'The dimensions of reproductive ill-health. 1990-1995', Geneva, 1995.
634. WHO, 'Fifty facts from The World Health Report 1998: Global health situation and trends 1955-2025', Geneva, 1998.
635. Williams, D. and Williams, G., Every Child a Wanted Child: Clarence James Gamble, M.D., and his Work in the Birth Control Movement, ed. E. P. Flint (Boston, 1978).
636. Williams, D. et al., 'Effect of the British warning on contraceptive use in the General Medical Service in Ireland', Irish Medical Journal, 91/6 (Dec. 1999).
637. Williams-Deane, M. and Potter, L. S., 'Current oral contraceptive use instructions: An analysis of patient package inserts', Family Planning Perspectives, 24/3 (May/June 1992), 111-15.
638. Wilmsen, E., Journeys with Flies (Chicago, 1999).
639. Wingo, P. A. et al., 'Age specific differences in the relationship between oral contraceptive use and breast cancer', Obstetrics and Gynaecology, 78/2 (1991) 161-70.
640. Wiseman, A., 'Oral contraceptives in family planning', Journal of the College of General Practice of Canada (June 1966), 18-21.
641. Wiseman, A., 'Should you tell your daughter?', Evening Standard, 4 Nov. 1966.
642. Wiseman, A., 'Six years' experience of oral contraception in a family planning clinic', Clinical Trials Journal, 5 (Jan. 1968), 117-24.
643. 'Women as guinea pigs, the continuing saga', Critical List (Summer 1977), 25-6.
644. Wood, C., Birth Control Now and Tomorrow (Gateshead, 1969).
645. Woolf, M., Family Intentions (London, 1971).
646. Wynn, V. and Doar, J. W. H., 'Some effects of oral contraceptives on carbohydrate metabolism', Lancet, 2 (1 Oct. 1966), 715-23.
647. Yuncker, B., 'Researcher predicts ban on the pill', New York Post, 22 Dec. 1969, 3.
648. Yuncker, B., 'A reporter finds a cause', New York Post, 24 Jan. 1970, 21.
649. Zaffaroni, A., 'From Paper Chromatography to Drug Discovery', Steroids, 57 (Dec. 1992), 642-8.
650. Zaremba, M., 'A victim of the record-years', Dagens Nyheter, trans. S. Croall (27 Sept. 1997).